Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serotonin in Compulsive Behavior
NCT04336228Phase 4Active, not recruiting
- Sponsor
- Rigshospitalet
- Start
- Apr 2020
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Escitalopram oxalate oral solution in obsessive compulsive disorder (OCD), sponsored by Rigshospitalet. Started Apr 2020; status: active, not recruiting.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT04336228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04336228.